Physician profile
Nicholas Leone
NPI 1386700789
$12,916.47
in general payments reported to CMS, 2019-2025
54 companies · $2,348 in 2025
The $2,348 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,660 · 2020: $475 · 2021: $1,710 · 2022: $2,110 · 2023: $2,201 · 2024: $2,413 · 2025: $2,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,715 · Travel and Lodging: $230 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,715.28 |
| Travel and Lodging | $230.00 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,165.55 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Sumitomo Pharma America, INC. | $1,038.11 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $944.83 | 2019-2024 | Myrbetriq, Veozah, Xtandi |
| Teleflex LLC | $821.79 | 2021-2025 | Barrigel |
| Janssen Biotech, INC. | $651.27 | 2019-2025 | Erleada, Akeega |
| Ferring Pharmaceuticals INC. | $558.44 | 2019-2025 | Adstiladrin |
| Dornier Medtech America, INC | $520.67 | 2023 | Dornier Medtech |
| Bayer Healthcare Pharmaceuticals INC. | $491.70 | 2019-2025 | |
| Urovant Sciences INC | $491.33 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $415.65 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $408.44 | 2019-2024 | Aveed, Xiaflex |
| Tolmar Pharmaceuticals, INC. | $379.39 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $360.28 | 2022-2025 | Pylarify |
| Myriad Genetic Laboratories, INC. | $350.79 | 2021-2023 | Prolaris |
| Pfizer INC. | $320.68 | 2019-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $300.05 | 2022-2023 | Itind System |
| Amgen INC. | $274.71 | 2019-2022 | |
| Abbvie INC. | $262.53 | 2019-2025 | |
| Medtronic, INC. | $251.97 | 2023-2024 | Interstim |
| Tolmar, INC. | $245.36 | 2023-2025 | Eligard, Jatenzo |
| Sn Holdings, LLC | $230.00 | 2023 | |
| Merck Sharp & Dohme LLC | $223.50 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Novartis Pharmaceuticals Corporation | $187.17 | 2023-2025 | |
| Immunitybio, INC. | $179.20 | 2024-2025 | |
| Urogen Pharma, INC. | $169.31 | 2022-2025 | |
| Neotract INC. | $130.65 | 2019 | |
| Clarus Therapeutics INC. | $117.01 | 2021 | |
| Accord Healthcare, INC. | $114.98 | 2023-2024 | |
| Bioprotect Medical, INC. | $114.60 | 2024-2025 | Bioprotect Balloon Implant System |
| Endo USA, INC. | $113.47 | 2024-2025 | Aveed, Xiaflex |
| Janssen Pharmaceuticals, INC | $109.47 | 2019-2025 | Erleada |
| Antares Pharma, INC. | $96.95 | 2019-2023 | Nocdurna, Xyosted, Tlando |
| Medtronic USA, INC. | $91.77 | 2019 | |
| Renovia INC | $82.48 | 2019 | |
| 180 Medical, INC. | $70.05 | 2022-2025 | Gentlecath Glide |
| Coloplast Corp | $66.48 | 2024-2025 | |
| Tempus Ai, INC | $65.58 | 2024-2025 | Xt Cdx |
| Rochester Medical Corporation | $61.09 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $57.69 | 2025 | |
| Myovant Sciences INC. | $48.53 | 2021-2022 | |
| Caris Mpi, INC. | $44.21 | 2025 | Mi Cancer Seek |
| Blue Earth Diagnostics | $35.86 | 2019-2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $34.12 | 2019 | |
| Convatec INC. | $32.10 | 2021 | |
| Genzyme Corporation | $30.82 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $29.88 | 2019 | |
| Palette Life Sciences, INC. | $23.97 | 2022 | |
| Allergan, INC. | $23.27 | 2019 | |
| Verity Pharmaceuticals INC. | $22.01 | 2025 | Trelstar |
| Metuchen Pharmaceuticals | $16.77 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $15.06 | 2022 | |
| Zyla Life Sciences, INC. | $12.94 | 2020 | |
| Clovis Oncology, INC. | $11.94 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Leone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.